Company Filing History:
3 out of 15,502 
3 out of 5,309 
2 out of 53 
Years Active: 2020-2022
Title: Daniela Gisela Dengler: Innovator in Mu Opioid Receptor Modulation
Introduction
Daniela Gisela Dengler is a prominent inventor based in Erlangen, Germany. She has made significant contributions to the field of pharmacology, particularly in the modulation of mu opioid receptors. With a total of three patents to her name, her work has the potential to impact pain management and opioid-related therapies.
Latest Patents
Dengler's latest patents focus on mu opioid receptor modulators. These patents describe compositions and methods for modulating mu opioid receptor activity, which is crucial for developing new therapeutic strategies in pain management. The innovative approaches outlined in her patents could lead to advancements in how opioid medications are utilized.
Career Highlights
Throughout her career, Daniela has worked with esteemed institutions such as the University of California and Leland Stanford Junior University. Her experience in these prestigious organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Dengler has collaborated with notable colleagues, including Brian K. Shoichet and Peter Gmeiner. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Daniela Gisela Dengler is a trailblazer in the field of mu opioid receptor modulation. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient care.